January 12, 2006

Early treatment‐related mortality in adult autologous stem cell transplant recipients: a nation‐wide survey of 1482 transplanted patients

Key Points

Key points are not available for this paper at this time.

Abstract

This nation-wide survey indicated a low early TRM in ASCT recipients in general, but higher risks in patients with AL amyloidosis or NHL. In addition to patient selection, also optimization of transplant procedure may be needed in these patient groups to reduce early TRM.

Bookmark

Cite This Study

Jantunen et al. (Thu,) studied this question.

synapsesocial.com/papers/69d96def9a6164e50fa3cc7f https://doi.org/https://doi.org/10.1111/j.1600-0609.2005.00605.x

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Stem Cell Transplantation for Peripheral T-Cell Lymphomas2003 · 25 citations
2High-dose chemotherapy with BEAC regimen and autologous bone marrow transplantation for intermediate grade and immunoblastic lymphoma: durable complete remissions, but a high rate of regimen-related toxicity.1995 · 53 citations
3Outcome of 5651 hematopoietic stem cell transplants for hematological malignancies carried out in Europe in 1993: a reliability study of the registry2002 · 7 citations
4Stem cell transplantation for chronic lymphocytic leukemia: should not more patients get a transplant?2004 · 16 citations
5Haematopoietic stem cell transplantation (HSCT) in Europe 2002. Changes in indication and impact of team density. A report of the EBMT activity survey2004 · 52 citations

Bookmark